ISDS Case Map
health
The 2026 NTE Report makes it clear that the Trump administration’s primary motivation behind its trade policy is to protect the profits of big US companies.
A pharma row between Switzerland and the U.K. risks derailing trade talks, with British officials concerned Swiss demands could push up NHS bills.
The EU-India FTA promises cheaper drugs and medical devices, but India's regulatory framework may hinder patient benefits. Current pricing mechanisms, including market-based ceiling prices and loopholes for fixed-dose combinations, prevent cost reductions from reflecting in retail prices. An urgent overhaul of drug pricing and an independent regulator for procedures are needed to ensure affordability and realize the FTA's full potential.
The Working Group points out that the European Commission's press release states the agreement provides for a high level of protection and enforcement of Intellectual Property rights, including copyright, trademarks, designs, trade secrets and plant variety rights.
The administration said it would pursue similar deals with other countries that have not yet locked in trade agreements with the US to correct a longstanding gripe Trump has had with wealthy European nations that he says pay too little for medicines.
The United States announced a deal with Britain for zero tariffs on pharmaceutical products and medical technology which will lead to Britain spending more on medicines.
A flurry of new tariff announcements on pharma, trucks and movies have left British officials scrambling to keep up.
The Forum for Trade Justice condemns the UK-India CETA for allowing India to make severe concessions that undermine its ability to maintain public health safeguards, control digital data sovereignty, and protect domestic industries, while the promised export gains are minimal or illusory.
Malaysian CSOs have urged the government to reject the inclusion of the ISDS clause in the RCEP agreement. They warn that ISDS allows foreign investors to sue governments over policies safeguarding public interests like health, workers, and the environment, potentially leading to costly legal battles and large payouts detrimental to national budgets.
On January 14, President William Ruto and UAE President Sheikh Mohamed bin Zayed Al Nahyan signed the Kenya-United Arab Emirates Comprehensive Economic Partnership Agreement (CEPA), touted as the UAE’s first such deal with a mainland African country.
